Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Gland Pharma has scheduled one-on-one meetings with institutional investors and analysts. These engagements include ICICI Prudential AMC and Jefferies on June 19, 2026, and Valuequest Investment Advisors on June 25, 2026.
Jun 16 2026 17:40:24
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of Director
Gland Pharma's Independent Director, Mr. Satyanarayana Murthy Chavali, resigned effective June 15, 2026. The resignation is due to a potential conflict of interest as another company, where Mr. Chavali is a promoter and director, proposes to enter a business segment similar to Gland Pharma's future plans.
Jun 16 2026 16:12:20
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of Director
Gland Pharma's Independent Director Mr. Satyanarayana Murthy Chavali resigned from the Board effective June 15, 2026. The resignation is due to a potential conflict of interest as a promoter-led company he is involved with plans to enter similar business segments as Gland Pharma.
Jun 15 2026 16:48:22
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate
Gland Pharma's Board of Directors announced the resignation of Independent Director Mr. Satyanarayana Murthy Chavali due to a potential conflict of interest. Concurrently, Mr. Udo Jahannes Vetter was re-appointed as an Independent Director for a second term, and Mr. William Robert Keller was appointed as an Additional Independent Director.
Jun 15 2026 16:45:20
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting - 15.06.2026
Gland Pharma's Board re-appointed Mr. Udo Vetter and appointed Mr. William Keller as Independent Directors. Two IDs resigned, with Mr. S.M. Chavali citing potential conflict of interest regarding the company's future business plans. Board committees realigned.
Jun 15 2026 16:42:32
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings in June 2026. The meetings include a one-on-one with Carnelian Asset Management and participation in the ICICI Securities India Investor Conference.
May 26 2026 15:34:26
Read More